Multifactorial Intervention to Reduce Cardiovascular Events in Type 2 Diabetes

被引:17
|
作者
Rajpathak, Swapnil N. [2 ]
Aggarwal, Vikas [2 ]
Hu, Frank B. [1 ]
机构
[1] Harvard Univ, Sch Publ Hlth, Dept Nutr & Epidemiol, Boston, MA 02115 USA
[2] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, New York, NY USA
关键词
Diabetes; Cardiovascular disease; Multifactorial intervention; Lifestyle intervention; Nutrition; Lipids; Obesity; Hypertension; Hypoglycemia; CORONARY-HEART-DISEASE; WHOLE-GRAIN INTAKE; GLUCOSE CONTROL; DIETARY FIBER; GLYCEMIC LOAD; COST-EFFECTIVENESS; PHYSICAL-ACTIVITY; TOTAL MORTALITY; RISK; MELLITUS;
D O I
10.1007/s11892-009-0084-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Type 2 diabetes is associated with a significantly increased risk of cardiovascular disease (CVD) morbidity and mortality. Although several clinical trials have evaluated the effects of interventions to reduce CVD risk in people with diabetes, such studies are primarily conducted to target individual risk factors such as hypertension, hyperglycemia, and dyslipidemia rather than using a multifactorial interventional approach. Existing clinical trial data suggest that intensive multifactorial interventions that target several important risk factors simultaneously result in a significantly greater risk reduction in CVD risk compared with single risk factor interventions. However, few studies have evaluated the efficacy and effectiveness of such interventions on CVD hard end points. A multidisciplinary team management of diabetes should focus on weight control, diet, physical activity, diabetes education, and adherence to pharmacotherapy. An individually tailored aggressive management program to reduce multiple CVD risk factors simultaneously has great potential to prevent CVD morbidity and mortality among patients with type 2 diabetes.
引用
收藏
页码:16 / 23
页数:8
相关论文
共 50 条
  • [21] Canagliflozin and cardiovascular and renal events in type 2 diabetes
    Guthrie, Robert
    POSTGRADUATE MEDICINE, 2018, 130 (02) : 149 - 153
  • [22] Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
    Fernandez-Balsells, M. Merce
    Sojo-Vega, Lidia
    Ricart-Engel, Wifredo
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (21): : 2098 - 2098
  • [23] Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
    Neal, Bruce
    Perkovic, Vlado
    Mahaffey, Kenneth W.
    de Zeeuw, Dick
    Fulcher, Greg
    Erondu, Ngozi
    Shaw, Wayne
    Law, Gordon
    Desai, Mehul
    Matthews, David R.
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (07): : 644 - 657
  • [24] A targeted, multifactorial intervention reduced mortality in patients with type 2 diabetes and microalbuminuria
    Ganda, Om P.
    ANNALS OF INTERNAL MEDICINE, 2008, 149 (04)
  • [25] Multifactorial intervention in Type 2 diabetes: The promise of incretin-based therapies
    F. Giorgino
    A. Leonardini
    A. Natalicchio
    L. Laviola
    Journal of Endocrinological Investigation, 2011, 34 : 69 - 77
  • [26] Cardiovascular effects of a lifestyle intervention in type 2 diabetes
    Scherbaum, W. A.
    Nitschmann, S.
    INTERNIST, 2014, 55 (06): : 735 - 737
  • [27] The steno-2 study: Intensified multifactorial intervention reduces the risk of cardiovascular disease in patients with type 2 diabetes and microalbuminuria.
    Gaede, P
    Vedel, P
    Larsen, N
    Jensen, G
    Parving, HH
    Pedersen, O
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 : 7A - 7A
  • [28] Cardiovascular risk factors in type 2 diabetic patients:: Multifactorial intervention in primary care
    Tranchie, S
    Galgo, A
    Mundet, X
    Sánchez-Zamorano, MA
    KIDNEY INTERNATIONAL, 2005, 67 : S55 - S62
  • [29] Lipid management to reduce cardiovascular risk in type 2 diabetes
    Brandts, Julia
    DIABETOLOGIE, 2023, 19 (08): : 877 - 884
  • [30] Therapeutic targets to reduce cardiovascular disease in type 2 diabetes
    Cyrus DeSouza
    Vivian Fonseca
    Nature Reviews Drug Discovery, 2009, 8 (5) : 361 - 367